Tamgiblimab (IBI939) is a fully humanized monoclonal antibody targeting TIGIT (T-cell immunoreceptor with immunoglobulin and ITIM domains), applicable for cancer research.
Purity:
95.00%
CAS Number:
[2411914-36-6]
Target:
Immunology/Inflammation related
* VAT and and shipping costs not included. Errors and price changes excepted